January 25, 2023

Pliant Therapeutics

Pliant Therapeutics Announces Appointment of Lily Cheung as Chief Human Resources Officer

January 25, 2023

Magenta Therapeutics

Magenta Therapeutics Voluntarily Pauses The MGTA-117 Phase 1/2 Dose-Escalation Clinical Trial To Investigate Drug Safety

January 24, 2023

Pliant Therapeutics

Pliant Therapeutics Announces Pricing of Upsized $250.0 Million Public Offering

January 24, 2023

Decibel Therapeutics

Decibel Therapeutics Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Lead Gene Therapy Candidate DB-OTO

January 22, 2023

Pliant Therapeutics

Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary Fibrosis

Load More

Sign up for weekly portfolio news.